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Immunotherapy with house dust extract IS
employed as a treatment of patients with
house dust mite sensitive bronchial asthma.
Although 70-80% efficacy of the treatment
is reported, mechanisms of its efficacy are
not clear yet. In this paper, reported studies
of IgE antibody, IgG antibody, IgG4 anti-
body, antiidiotypic antibody, reactivity of
mast cells and function of lymphocytes are
reviewed. A new type of immunotherapy with
allergen antibody immune complex and a
potential use of influenza virus hemaglutinin
peptide analogue are also referred.
